TrialAIDS (London, England)2013

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.

Richard M Novak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.